Fundraising FoxBectas Therapeutics
Houston, US · Founded 2022 · Delaware corporation
Find your way into Bectas Therapeutics
Sign up to see every warm intro you have to Bectas Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Bectas Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Bectas Therapeutics is a biotech company operating in the therapeutic development space. The page features CEO Ronan O'Hagan discussing biotech industry insights, leadership, team building, and organizational culture.
Founders & leadership
JA
Jon A. BrilliantExecutive
RO
Ronan O'HaganCEO and President
RC
Ronan C. O'HaganPresident & CEO
Board
LC
Lynda ChinBoard director
Reported raises · per SEC filings
Form D private placements$5.5M disclosed across 1 of 2 rounds · 2022–2024
▶$5.5MraisedOct 2025 · 13 investors · BiotechnologyRule 506(b)
▶$5.5MraisedOct 2025 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jon A. BrilliantExecutive Officer
- Ronan O'HaganExecutive Officer, Director
- Lynda ChinDirector
- Offering amount
- $10M
- Amount sold
- $5.5M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Cabaletta BioCabaletta Bio is a clinical-stage biotechnology company developing engineered T cell therapies for patients with autoimmune diseases. Its CABA platform and lead CARTA program center on rese-cel, an investigational CD19-CAR T cell therapy being evaluated in trials across rheumatology, neurology, and dermatology.
Beam TherapeuticsBeam Therapeutics develops gene-editing medicines, particularly base editors and precision genome editing technologies, to create lifelong cures for patients with serious genetic diseases. The company works across multiple therapeutic areas to advance precision medicine treatments at the molecular level.
Companies working in the same space as Bectas Therapeutics.
In the news
Frequently asked questions
- What does Bectas Therapeutics do?
- Bectas Therapeutics is a biotech company operating in the therapeutic development space. The page features CEO Ronan O'Hagan discussing biotech industry insights, leadership, team building, and organizational culture.
- How much funding has Bectas Therapeutics raised?
- Bectas Therapeutics has disclosed $5.5M raised across 1 of its 2 known rounds.
- Where is Bectas Therapeutics headquartered?
- Bectas Therapeutics is headquartered in Houston, US.